10-Q Filing

REGENXBIO Inc. CIK: 1590877 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-022765`
Period End Date	20170930
Filing Date	20171108
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	rgnx-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 76 Cash Flow Statement 62 Comprehensive Income 2

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.11M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$59.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$106.78M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$64.71M	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$1.03M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$884.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.23M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.77M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.39M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.11M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.01M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.48M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$172.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$93.37M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.48M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.11M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$69.41M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$24.48M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.32M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.55M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$400.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$836.00K	USD	Point-in-time
Total assets	`Assets`	$209.25M	USD	Point-in-time
Total assets	`Assets`	$172.73M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.59M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.54M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$10.80M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$8.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.67M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.33M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$14.60M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2017 and December 31, 2016; 31,109 and 26,477 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2017 and December 31, 2016; 31,109 and 26,477 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$366.96M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$276.35M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-33.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-553.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-114.59M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-171.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$161.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$194.65M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$209.25M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$172.73M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
License revenue	`LicensesRevenue`	$2.64M	USD	3 Qtrs
License revenue	`LicensesRevenue`	$8.35M	USD	3 Qtrs
License revenue	`LicensesRevenue`	$1.33M	USD	1 Quarter
License revenue	`LicensesRevenue`	$65.00K	USD	1 Quarter
Reagent sales	`OtherSalesRevenueNet`	$47.00K	USD	1 Quarter
Reagent sales	`OtherSalesRevenueNet`	$213.00K	USD	3 Qtrs
Grant revenue	`RevenueFromGrants`	$8.00K	USD	3 Qtrs
Grant revenue	`RevenueFromGrants`	$13.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$1.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$42.00K	USD	3 Qtrs
Total revenues	`Revenues`	$8.35M	USD	3 Qtrs
Total revenues	`Revenues`	$125.00K	USD	1 Quarter
Total revenues	`Revenues`	$2.89M	USD	3 Qtrs
Total revenues	`Revenues`	$1.34M	USD	1 Quarter
Licensing costs	`LicenseCosts`	$683.00K	USD	1 Quarter
Licensing costs	`LicenseCosts`	$528.00K	USD	3 Qtrs
Licensing costs	`LicenseCosts`	$13.00K	USD	1 Quarter
Licensing costs	`LicenseCosts`	$2.08M	USD	3 Qtrs
Costs of reagent sales	`CostOfGoodsSold`	$22.00K	USD	1 Quarter
Costs of reagent sales	`CostOfGoodsSold`	$6.00K	USD	3 Qtrs
Costs of reagent sales	`CostOfGoodsSold`	$101.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$12.52M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$12.56M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$29.42M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$43.05M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$22.42M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.20M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$17.85M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.44M	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$2.00K	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$136.00K	USD	3 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-74.00K	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$47.76M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$67.64M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$22.64M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$18.79M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-44.87M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-59.29M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-21.31M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-18.67M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$603.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$1.51M	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$514.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$2.12M	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$514.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$603.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.12M	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$1.51M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-20.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-18.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.17M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-43.36M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net of reclassifications of $479 and $20 for the nine months ended September 30, 2017 and 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$332.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of reclassifications of $479 and $20 for the nine months ended September 30, 2017 and 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.57M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net of reclassifications of $479 and $20 for the nine months ended September 30, 2017 and 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-521.00K	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net of reclassifications of $479 and $20 for the nine months ended September 30, 2017 and 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$93.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.57M	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-521.00K	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$93.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$332.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-20.61M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.82M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-57.69M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-41.79M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-57.17M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-20.71M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-43.36M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.15M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.64	USD	3 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.69	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.67	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.94	USD	3 Qtrs
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	29.44M	shares	3 Qtrs
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.47M	shares	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.39M	shares	3 Qtrs
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.94M	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-57.17M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-43.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-18.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-20.71M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$5.03M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$7.81M	USD	3 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.50M	USD	3 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.41M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.96M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$264.00K	USD	3 Qtrs
Net realized gains on sales of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$479.00K	USD	3 Qtrs
Net realized gains on sales of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$20.00K	USD	3 Qtrs
Non-cash consideration received for licenses granted	`NonCashConsiderationReceivedForLicensesGrantedOperatingActivity`	$420.00K	USD	3 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-39.00K	USD	3 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$2.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-150.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.46M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.15M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.45M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$380.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.15M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$71.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$109.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$3.60M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.14M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$4.59M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.45M	USD	3 Qtrs
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$-127.00K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$1.30M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$-118.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-44.17M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-28.14M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$46.59M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$32.26M	USD	3 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$38.13M	USD	3 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$47.23M	USD	3 Qtrs
Sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$780.00K	USD	3 Qtrs
Sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$23.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.06M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.71M	USD	3 Qtrs
Restricted cash	`IncreaseDecreaseInRestrictedCash`	$225.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$1.95M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.65M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$752.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$174.00K	USD	3 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$556.00K	USD	3 Qtrs
Proceeds from public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStock`	$81.99M	USD	3 Qtrs
Issuance costs for public offering of common stock	`PaymentsOfStockIssuanceCosts`	$445.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$174.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$82.86M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$35.04M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-26.01M	USD	3 Qtrs
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$28.11M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$59.88M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$28.11M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$59.88M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.82M	USD	3 Qtrs
Non-cash consideration received for licenses granted	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	$420.00K	USD	3 Qtrs

Comprehensive Income 2 line items

Line Item	Tag	Value	Unit	Period
Unrealized gain (loss) on available-for-sale securities, net of reclassifications	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$479.00K	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net of reclassifications	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$20.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.